封面
市场调查报告书
商品编码
1705626

按资料类型、应用程式、最终使用者和地区分類的去识别健康资料市场

De-identified Health Data Market, By Type of Data, By Application, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 135 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2025 年全球去识别健康数据市场规模估计为 82.1 亿美元,预计到 2032 年将达到 153.1 亿美元,2025 年至 2032 年的复合年增长率为 9.3%。

报告范围 报告详细信息
基准年 2024 2025年的市场规模 82.1亿美元
效能数据 从2020年到2024年 预测期 2025年至2032年
预测期:2025-2032年复合年增长率: 9.30% 2032年价值预测 153.1亿美元
数字。 2025年各地区去识别化健康数据市场占有率(%)
去识别化健康数据市场-IMG1

去识别化医疗数据市场的成长受到药物发现和精准医疗研发活动不断增加的推动。去识别化透过从健康资料集中删除姓名、出生日期和社会安全号码等识别码来确保病患的隐私和机密性。这将使研究人员和生命科学公司能够利用大量健康数据来开发新的治疗方法和流行病学研究,而不会损害道德。随着全球健康记录数位化的加快,可供二次利用的去识别资料量将会增加。

市场动态

对基于价值的护理、个人化治疗和数位健康新兴企业的成长的日益关注可能会推动全球对去识别化医疗数据的需求。然而,缺乏数据标准化和智慧财产权模糊性可能会阻碍市场潜力的发挥。高阶分析能力的发展为企业提供了从其汇集的数据资产中获得更深入见解的机会。扩大政府开放资料共用倡议可以扩大对这些资料集的存取。美国政府推出了Data.gov和HealthData.gov等倡议,开放广泛的健康相关资料集,以促进公共卫生研究的透明度和创新。

本研究的主要特点

本报告对全球去识别化健康数据市场进行了详细分析,并提供了预测期(2025-2032 年)的市场规模(十亿美元)和年复合成长率(CAGR%),假设基准年为 2024 年。

它还强调了各个领域的潜在商机,并解释了该市场的引人注目的投资提案矩阵。

它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。

它根据公司亮点、产品系列、关键亮点、财务表现和策略等参数,对全球去识别健康数据市场中的主要企业进行了概述。

研究涉及的主要企业包括 IQVIA、 Oracle(Cerner Corporation)、Merative(Truven Health Analytics)、Optum, Inc.、BioTelemetry, Inc.、Flatiron Health、Veradigm LLC、Medidata Solutions、Evidation Health, Inc.、Komodo Health, Inc.、Sundown Solutions, LLC、Clarify Solutions、Akator Cyber​​Ltd.、Tempus、nference、Ciox Health、HealthVerity、Zebra Medical Vision 和 Huma Therapeutics。

本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。

全球去识别健康数据市场报告针对该行业的各个相关人员,包括投资者、供应商、产品製造商、经销商、新进入者和金融分析师。

相关人员可以透过用于分析全球去识别医疗数据市场的各种策略矩阵来简化决策。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要

第三章市场动态、法规与趋势分析

  • 市场动态
  • 司机
  • 限制因素
  • 机会
  • 影响分析
  • 主要进展
  • 监管情景
  • 产品发布/核准
  • PEST分析
  • 波特分析
  • 併购场景
  • 产业趋势

4. 2020 年至 2032 年按资料类型分類的去识别化健康资料市场

  • 临床数据
  • 基因组数据
  • 患者人口统计
  • 处方数据
  • 帐单数据
  • 行为数据
  • 穿戴式装置和感测器数据
  • 调查和患者报告数据
  • 影像资料
  • 检查数据
  • 健康社会决定因素 (SDOH) 数据
  • 其他的

5. 2020 年至 2032 年去识别化健康资料市场(依应用划分)

  • 临床研究与试验
  • 公共卫生
  • 精准医疗
  • 健康经济学与成果研究(HEOR)
  • 人口健康管理
  • 药物研发
  • 提高医疗保健品质
  • 核保和风险评估
  • 其他的

6. 2020 年至 2032 年去识别化健康资料市场(依最终使用者划分)

  • 製药公司
  • 生技公司
  • 医疗保健提供者
  • 保险公司/医疗保健支付者
  • 研究组织
  • 政府
  • 其他的

7. 2020 年至 2032 年各地区去识别化健康资料市场

  • 北美洲
  • 拉丁美洲
  • 欧洲
  • 亚太地区
  • 中东
  • 非洲

第八章 竞争态势

  • IQVIA
  • Oracle(Cerner Corporation)
  • Merative(Truven Health Analytics)
  • Optum, Inc.
  • BioTelemetry, Inc.
  • Flatiron Health
  • Veradigm LLC
  • Medidata Solutions
  • Evidation Health, Inc.
  • Komodo Health, Inc.
  • Sundown Solutions, LLC
  • Clarify Health Solutions
  • Akrivia Health
  • Satori Cyber Ltd.
  • Tempus
  • nference
  • Ciox Health
  • HealthVerity
  • Zebra Medical Vision
  • Huma Therapeutics

第九章分析师建议

  • 命运之轮
  • 分析师观点
  • 一致的机会图

第十章参考文献与调查方法

  • 参考
  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI7476

Global De-identified Health Data Market is estimated to be valued at USD 8.21 Bn in 2025 and is expected to reach USD 15.31 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.3% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 8.21 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 9.30% 2032 Value Projection: USD 15.31 Bn
Figure. De-identified Health Data Market Share (%), By Region 2025
De-identified Health Data Market - IMG1

De-identified health data market growth is driven by increasing research and development activities for drug discovery and precision medicine. De-identification ensures patient privacy and confidentiality by removing identifiers such as name, date of birth, social security number, and others from health data sets. This allows researchers and life science companies to utilize large pools of health data for developing novel therapies and epidemiological studies without compromising on ethics. As digitization of health records accelerates across the world, there will be increase in amount of de-identified data available for secondary usage.

Market Dynamics

Rising focus on value-based care, personalization of treatment, and growth of digital health startups can boost demand for de-identified health data globally. However, lack of data standardization and ambiguity over intellectual property rights can hamper the market potential. Development of advanced analytics capabilities offers an opportunity for players to unlock deeper insights from pooled data assets. Growing open data sharing initiatives by governments can widen the access to these data sets. The U.S. government has launched initiatives like Data.gov and HealthData.gov that offers open access to a wide range of health-related datasets to encourage transparency and innovation in public health research.

Key features of the study

This report provides in-depth analysis of the global de-identified health data market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global de-identified health data market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include IQVIA, Oracle (Cerner Corporation), Merative (Truven Health Analytics), Optum, Inc., BioTelemetry, Inc., Flatiron Health, Veradigm LLC, Medidata Solutions, Evidation Health, Inc., Komodo Health, Inc., Sundown Solutions, LLC, Clarify Health Solutions, Akrivia Health, Satori Cyber Ltd., Tempus, nference, Ciox Health, HealthVerity, Zebra Medical Vision, and Huma Therapeutics

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global de-identified health data market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global de-identified health data market

Market Segmentation

  • Type of Data Insights (Revenue, USD Bn, 2020 - 2032)
    • Clinical Data
    • Genomic Data
    • Patient Demographics
    • Prescription Data
    • Claims Data
    • Behavioral Data
    • Wearable and Sensor Data
    • Survey and Patient-Reported Data
    • Imaging Data
    • Laboratory Data
    • Social Determinants of Health (SDOH) Data
    • Others
  • Application Insights (Revenue, USD Bn, 2020 - 2032)
    • Clinical Research and Trials
    • Public Health
    • Precision Medicine
    • Health Economics and Outcomes Research (HEOR)
    • Population Health Management
    • Drug Discovery and Development
    • Healthcare Quality Improvement
    • Insurance Underwriting and Risk Assessment
    • Others
  • End User Insights (Revenue, USD Bn, 2020 - 2032)
    • Pharmaceutical Companies
    • Biotechnology Firms
    • Healthcare Providers
    • Insurance Companies/Healthcare Payers
    • Research Institutions
    • Government Agencies
    • Others
  • Regional Insights (Revenue, USD Bn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • IQVIA
    • Oracle (Cerner Corporation)
    • Merative (Truven Health Analytics)
    • Optum, Inc.
    • BioTelemetry, Inc.
    • Flatiron Health
    • Veradigm LLC
    • Medidata Solutions
    • Evidation Health, Inc.
    • Komodo Health, Inc.
    • Sundown Solutions, LLC
    • Clarify Health Solutions
    • Akrivia Health
    • Satori Cyber Ltd.
    • Tempus
    • nference
    • Ciox Health
    • HealthVerity
    • Zebra Medical Vision
    • Huma Therapeutics

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • De-identified Health Data Market, By Type of Data
    • De-identified Health Data Market, By Application
    • De-identified Health Data Market, By End User
    • De-identified Health Data Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. De-identified Health Data Market, By Type of Data, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Clinical Data
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Genomic Data
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Patient Demographics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Prescription Data
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Claims Data
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Behavioral Data
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Wearable and Sensor Data
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Survey and Patient-Reported Data
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Imaging Data
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Laboratory Data
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Social Determinants of Health (SDOH) Data
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. De-identified Health Data Market, By Application, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Clinical Research and Trials
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Public Health
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Precision Medicine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Health Economics and Outcomes Research (HEOR)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Population Health Management
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Drug Discovery and Development
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Healthcare Quality Improvement
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Insurance Underwriting and Risk Assessment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. De-identified Health Data Market, By End User, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Pharmaceutical Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Biotechnology Firms
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Healthcare Providers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Insurance Companies/Healthcare Payers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Research Institutions
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Government Agencies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. De-identified Health Data Market, By Region, 2020 - 2032, (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2025,2028 & 2032, (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Type of Data, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Type of Data, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Type of Data, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Type of Data, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Type of Data, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Type of Data, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

8. Competitive landscape

  • IQVIA
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Oracle (Cerner Corporation)
  • Merative (Truven Health Analytics)
  • Optum, Inc.
  • BioTelemetry, Inc.
  • Flatiron Health
  • Veradigm LLC
  • Medidata Solutions
  • Evidation Health, Inc.
  • Komodo Health, Inc.
  • Sundown Solutions, LLC
  • Clarify Health Solutions
  • Akrivia Health
  • Satori Cyber Ltd.
  • Tempus
  • nference
  • Ciox Health
  • HealthVerity
  • Zebra Medical Vision
  • Huma Therapeutics

9. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

10. References and Research Methodology

  • References
  • Research Methodology
  • About us